Additional file 5: of The Cambridge Prognostic Groups for improved prediction of disease mortality at diagnosis in primary non-metastatic prostate cancer: a validation study

Table S5. Distribution of cases/deaths and sub-hazard ratios from competing risk analysis for each Cambridge Prognostic Group (CPG) in the Singapore cohort (n = 2550). (DOCX 15 kb)